Advertisement
Canada markets closed

  • S&P/TSX

    21,807.37
    +98.93 (+0.46%)
     

  • S&P 500

    4,967.23
    -43.89 (-0.88%)
     

  • DOW

    37,986.40
    +211.02 (+0.56%)
     

  • CAD/USD

    0.7275
    +0.0012 (+0.16%)
     

  • CRUDE OIL

    83.24
    +0.51 (+0.62%)
     

  • Bitcoin CAD

    88,514.24
    +1,059.55 (+1.21%)
     

  • CMC Crypto 200

    1,334.09
    +21.46 (+1.64%)
     

  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     

  • RUSSELL 2000

    1,947.66
    +4.70 (+0.24%)
     

  • 10-Yr Bond

    4.6150
    -0.0320 (-0.69%)
     

  • NASDAQ

    15,282.01
    -319.49 (-2.05%)
     

  • VOLATILITY

    18.71
    +0.71 (+3.94%)
     

  • FTSE

    7,895.85
    +18.80 (+0.24%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • CAD/EUR

    0.6824
    +0.0003 (+0.04%)
     

Knol Resources Corp. and Pivot Pharmaceuticals Inc. Mutually Agree to Terminate Letter of Intent

Newsfile Corp.
Updated

Vancouver, British Columbia--(Newsfile Corp. - November 14, 2018) - Knol Resources Corp. (TSXV: NOL.H) (the "Corporation") and Pivot Pharmaceuticals Inc. announce that they have mutually agreed to terminate their previously announced Letter of Intent dated October 3, 2018.

Accordingly, it is anticipated that the common shares of Knol will resume trading at the open of the market on Friday, November 16, 2018.

For further information, please contact:

Michael Atkinson, President and Chief Executive Officer of Knol Resources Corp.
Email: atkinson@earlston.ca
Phone: (604) 689-1428

Neither the TSX Venture Exchange nor it Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.